Literature DB >> 18837785

The bacterial superantigen and superantigen-like proteins.

John D Fraser1, Thomas Proft.   

Abstract

SUMMARY: The bacterial superantigens are protein toxins that bind to major histocompatibility complex class II and T-cell receptor to stimulate large numbers of T cells. The majority are produced by the Gram-positive organisms Staphylococcus aureus and Streptococcus pyogenes and are the causative agents in toxic shock syndrome, an acute disease caused by the sudden and massive release of T-cell cytokines into the blood stream. The structure and function of the superantigens has revealed a common architecture that is also shared by another group of staphylococcal virulence factors called the superantigen-like proteins (SSL). Together, this family of structurally related molecules highlights how a common pathogenic organism has employed a simple but adaptable protein to generate an armamentarium of potent defense molecules designed to target of the innate and adaptive immune response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18837785     DOI: 10.1111/j.1600-065X.2008.00681.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  178 in total

1.  Metabolic sensor governing bacterial virulence in Staphylococcus aureus.

Authors:  Yue Ding; Xing Liu; Feifei Chen; Hongxia Di; Bin Xu; Lu Zhou; Xin Deng; Min Wu; Cai-Guang Yang; Lefu Lan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

2.  Amygdaloid signature of peripheral immune activation by bacterial lipopolysaccharide or staphylococcal enterotoxin B.

Authors:  Geraldine Prager; Martin Hadamitzky; Andrea Engler; Raphael Doenlen; Timo Wirth; Gustavo Pacheco-López; Ute Krügel; Manfred Schedlowski; Harald Engler
Journal:  J Neuroimmune Pharmacol       Date:  2012-05-27       Impact factor: 4.147

3.  The structure of superantigen complexed with TCR and MHC reveals novel insights into superantigenic T cell activation.

Authors:  Maria Saline; Karin E J Rödström; Gerhard Fischer; Vladislav Yu Orekhov; B Göran Karlsson; Karin Lindkvist-Petersson
Journal:  Nat Commun       Date:  2010-11-16       Impact factor: 14.919

4.  Antigen targeting to major histocompatibility complex class II with streptococcal mitogenic exotoxin Z-2 M1, a superantigen-based vaccine carrier.

Authors:  Fiona J Radcliff; Jacelyn M S Loh; Birgit Ha; Diana Schuhbauer; James McCluskey; John D Fraser
Journal:  Clin Vaccine Immunol       Date:  2012-02-01

5.  Enterotoxins can support CAR T cells against solid tumors.

Authors:  Bianca von Scheidt; Minyu Wang; Amanda J Oliver; Jack D Chan; Metta K Jana; Aesha I Ali; Fiona Clow; John D Fraser; Kylie M Quinn; Phillip K Darcy; Michael H Kershaw; Clare Y Slaney
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-25       Impact factor: 11.205

Review 6.  Staphylococcal manipulation of host immune responses.

Authors:  Vilasack Thammavongsa; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Nat Rev Microbiol       Date:  2015-09       Impact factor: 60.633

Review 7.  The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

8.  Characterization of the Staphylococcal enterotoxin A: Vβ receptor interaction using human receptor fragments engineered for high affinity.

Authors:  P Sharma; S Postel; E J Sundberg; D M Kranz
Journal:  Protein Eng Des Sel       Date:  2013-10-27       Impact factor: 1.650

9.  Enhanced interaction between SEC2 mutant and TCR Vβ induces MHC II-independent activation of T cells via PKCθ/NF-κB and IL-2R/STAT5 signaling pathways.

Authors:  Xuanhe Fu; Mingkai Xu; Yubo Song; Yongqiang Li; Huiwen Zhang; Jinghai Zhang; Chenggang Zhang
Journal:  J Biol Chem       Date:  2018-10-23       Impact factor: 5.157

10.  Systemic inflammatory response elicited by superantigen destabilizes T regulatory cells, rendering them ineffective during toxic shock syndrome.

Authors:  Ashenafi Y Tilahun; Vaidehi R Chowdhary; Chella S David; Govindarajan Rajagopalan
Journal:  J Immunol       Date:  2014-08-04       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.